Lebray P - Search Results

1

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.

Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, Ratziu V; LIDO Study Group. Pais R, et al. Among authors: lebray p. J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9. J Hepatol. 2013. PMID: 23665288

2

NNRTI-related or -unrelated hepatotoxicity?

Lebray P, Benhamou Y, Pol S, Myers RP, Poynard T, Di Martino V. Lebray P, et al. Hepatology. 2002 Aug;36(2):512-3; author reply 513-4. doi: 10.1053/jhep.2002.34295. Hepatology. 2002. PMID: 12143068 No abstract available.

3

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.

Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Di Martino V, et al. Among authors: lebray p. Hepatology. 2004 Dec;40(6):1426-33. doi: 10.1002/hep.20463. Hepatology. 2004. PMID: 15565616

4

Natural history and predictors of disease severity in chronic hepatitis C.

Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, Poynard T. Massard J, et al. Among authors: lebray p. J Hepatol. 2006;44(1 Suppl):S19-24. doi: 10.1016/j.jhep.2005.11.009. Epub 2005 Nov 21. J Hepatol. 2006. PMID: 16356583 Review.

5

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, Lebray P, Thibault V, Benhamou Y, Moussalli J, Ratziu V, Poynard T. Ngo Y, et al. Among authors: lebray p. Clin Chem. 2006 Oct;52(10):1887-96. doi: 10.1373/clinchem.2006.070961. Epub 2006 Aug 24. Clin Chem. 2006. PMID: 16931569

6

Direct and indirect evidence for the reversibility of cirrhosis.

Serpaggi J, Carnot F, Nalpas B, Canioni D, Guéchot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S. Serpaggi J, et al. Among authors: lebray p. Hum Pathol. 2006 Dec;37(12):1519-26. doi: 10.1016/j.humpath.2006.07.007. Epub 2006 Sep 25. Hum Pathol. 2006. PMID: 16997354

7

[Can metabolic steatohepatitis be treated?].

Ratziu V, Vispo M, Tahiri M, Bonyhay L, de Torres M, Bernhardt C, Poynard T, Lebray P. Ratziu V, et al. Among authors: lebray p. Gastroenterol Clin Biol. 2007 Mar;31(3):333-40. doi: 10.1016/s0399-8320(07)89386-9. Gastroenterol Clin Biol. 2007. PMID: 17396098 Free article. Review. French. No abstract available.

8

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Morra R, Lebray P, Ingiliz P, Ngo Y, Munteanu M, Ratziu V, Poynard T. Morra R, et al. Among authors: lebray p. Hepatology. 2008 Jan;47(1):353-4; author reply 354-6. doi: 10.1002/hep.22046. Hepatology. 2008. PMID: 18161711 No abstract available.

9

FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.

Poynard T, Munteanu M, Ngo Y, Moussalli J, Lebray P, Thabut D, Benhamou Y, Ratziu V. Poynard T, et al. Among authors: lebray p. J Viral Hepat. 2008 Jun;15(6):472-3; author reply 474. doi: 10.1111/j.1365-2893.2008.00986.x. Epub 2008 Mar 24. J Viral Hepat. 2008. PMID: 18363670 No abstract available.

10

Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.

Munteanu M, Imbert-Bismut F, Messous D, Morra R, Thabut D, Lebray P, Benhamou Y, Ratziu V, Poynard T. Munteanu M, et al. Among authors: lebray p. Clin Biochem. 2008 Sep;41(13):1113-4. doi: 10.1016/j.clinbiochem.2008.04.020. Epub 2008 May 3. Clin Biochem. 2008. PMID: 18486610 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page